We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 27.50 | 1.59% | 1,761.00 | 1,757.50 | 1,758.00 | 1,767.00 | 1,736.00 | 1,736.00 | 14,302,622 | 16:35:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.69 | 72.38B |
From May 2019 to May 2024
TIDMGSK
RNS Number : 9414H
GlaxoSmithKline PLC
19 March 2015
GlaxoSmithKline plc (the "Company")
Director Declaration
In conformity with Listing Rule 9.6.14, the Company hereby notifies the market that Dr Daniel Podolsky, a Non-Executive Director of the Company, has been appointed as a Director to the Board of Agilent Technologies Inc. with effect from 21 July 2015.
V A Whyte
Company Secretary
19 March 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNEALDNFASSEFF
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
